- Home
- Gastroenterology
- The EMPA-KIDNEY Trial: Empagliflozin in Chronic Kidney Disease

5d3 min read
Medical Article
Introduction Chronic kidney disease (CKD) is a progressive condition often associated with decreased glomerular filtration rate (GFR) and albuminuria, which are significant risk factors for kidney failure (1). Slowing CKD progression and preventing dialysis or kidney transplantation are highly desirable due to their impact on quality of life, cardi

The EMPA-KIDNEY Trial: Empagliflozin in Chronic Kidney Disease
Similar Content

Single-incision Laparoscopy for Gastrostomy
407 Reached2 Comments1 Likes

Intestinal Obstruction and Ileocolic Fistula due to Gossypiboma
861 Reached30 Comments15 Likes

Woman with Complaint of Spontaneous Massive Rectal Prolapse
1864 Reached17 Comments9 Likes

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes

Pregnant Woman with HIV-1 Infection
747 Reached1 Likes